171 related articles for article (PubMed ID: 8568544)
1. Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections.
Paradisi F; Corti G
J Chemother; 1995 Aug; 7(4):338-43. PubMed ID: 8568544
[TBL] [Abstract][Full Text] [Related]
2. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic evaluation of once-daily aminoglycoside treatment.
Periti P
J Chemother; 1995 Aug; 7(4):380-94. PubMed ID: 8568549
[TBL] [Abstract][Full Text] [Related]
4. The place of tobramycin in lower respiratory tract infections (LRTI).
Gialdroni Grassi G
J Chemother; 1995 Aug; 7(4):344-54. PubMed ID: 8568545
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
Periti P
J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
[TBL] [Abstract][Full Text] [Related]
7. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Prescott WA
Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
[TBL] [Abstract][Full Text] [Related]
8. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycosides are useful for severe respiratory tract infections.
Craig WA; Andes D
Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954
[TBL] [Abstract][Full Text] [Related]
10. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
[TBL] [Abstract][Full Text] [Related]
11. Once-daily tobramycin in the treatment of adult patients with cystic fibrosis.
Whitehead A; Conway SP; Etherington C; Caldwell NA; Setchfield N; Bogle S
Eur Respir J; 2002 Feb; 19(2):303-9. PubMed ID: 11866010
[TBL] [Abstract][Full Text] [Related]
12. [Tobramycin--clinical pharmacology and chemotherapy].
Periti P
J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
14. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
Smyth A; Tan KH; Hyman-Taylor P; Mulheran M; Lewis S; Stableforth D; Prof Knox A;
Lancet; 2005 Feb 12-18; 365(9459):573-8. PubMed ID: 15708100
[TBL] [Abstract][Full Text] [Related]
15. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
Massie J; Cranswick N
J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
[TBL] [Abstract][Full Text] [Related]
17. What is the evidence for once-daily aminoglycoside therapy?
Barclay ML; Begg EJ; Hickling KG
Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
[TBL] [Abstract][Full Text] [Related]
19. Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.
Rozdzinski E; Kern WV; Reichle A; Moritz T; Schmeiser T; Gaus W; Kurrle E
J Antimicrob Chemother; 1993 Apr; 31(4):585-98. PubMed ID: 8514653
[TBL] [Abstract][Full Text] [Related]
20. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
